Walkky
Seth Lieberman is an experienced executive with a strong background in leadership and advisory roles across multiple companies. Currently serving as Chief Executive Officer of Ankored, Inc., a SaaS company focused on safety and compliance for youth activities, Seth also holds advisory and board positions with Meaningly, Walkky, CLIRNET, and previously with Beyond Pulse, Blank Label, and 42Floors. Prior experience includes founding and leading SnapApp, which specialized in conversational marketing, and serving as CEO of Pangea Media and Focalex, Inc., both of which operated in the digital marketing and lead generation sectors. Seth Lieberman earned a BA in Economics from Carleton College.
This person is not in any teams
Walkky
Heart-related death is a significant public health concern and a global leading cause of death. In the US cardiac arrest claims more than 300,000 lives annually. About 47% of sudden cardiac deaths occur outside a hospital. This suggests that many people with heart disease don’t act on early warning signs. Early predictions and out-of-hospital monitoring tools remain dismal. Our Solution is RESTful AI-powered analytics and alerting platform capable of accurately predicting heart issues based on Electrocardiogram (ECG) reads. Walkky analyzes ECG and builds a personal profile of the patient that is then used to detect, predict and alert of significant cardiac events and any abnormal or declining functions that deviate from the personal heart health of the patient. Our product is designed to provide immediate actionable analysis to the patient or the medical provider and therefore, reduce the time to provider intervention and substantially increase the patient’s quality of life. Our Technology is based on a novel method of bio-signal processing that we call Bio-Semantics™. Bio-Semantics™ principles are inspired from the field of natural language processing and semantic networks in the computer science discipline and brought into the medical data analysis arena. The essence of Bio Semantics™ is understanding the biological language of the heart in order to better diagnose and predict heart issues. Our Team includes startup executives, corporate leaders, top physicians and ivy league alumni and faculty. We have extensive experience in developing and bringing innovative software solutions to market. Our Vision is to build great technology that will revolutionize the way we process signals from the body and that will serve providers and medical device companies to incorporate AI better and help them build great products that will enhance patient’s lives.